Shingles, Prophylaxis

Medications for Herpes Zoster, Prophylaxis

Other names: Shingles, Prophylaxis

Around Herpes Zoster, Prophylaxis: Action taken to prevent Herpes zoster, an infection caused by a herpesvirus (varicella zoster virus).

This listing of medications are in some way associated with, or utilized in the treating this condition.

Medication name	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Zostavax	Rx	C	N	3 testimonials	5.5
Generic title: zoster vaccine live systemic Drug class: viral vaccines For customers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information

Shingrix	Rx		N	304 testimonials	4.8
Generic title: zoster vaccine, inactivated systemic Drug class: viral vaccines For customers: dosage, interactions, and side effects For professionals: AHFS DI Monograph

zoster vaccine reside	Rx	C	N	10 testimonials	3.4
Generic title: zoster vaccine live systemic Brand title: Zostavax Drug class: viral vaccines For customers: dosage, interactions, For professionals: Az Drug Truth, AHFS DI Monograph

zoster vaccine, inactivated	Rx		N	307 testimonials	4.8
Common title: zoster vaccine, inactivated systemic Brand title: Shingrix Drug class: viral vaccines For customers: dosage, interactions, For professionals: az Drug Truth, AHFS DI Monograph

Rx	prescription-only
OTC	On The Counter
Rx/OTC	Prescription or Over The Counter
Off Label	This medication may well not be approved by the FDA for the treatment of this condition.

Pregnancy Category
A	sufficient and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
C	Animal reproduction studies have demonstrated an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D	there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women obviously outweigh potential gains.
N	FDA has not classified the drug.

Controlled Substances Act (CSA) Schedule
N	Is not subject to the Controlled Substances Act.
1	features a higher potential for misuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision.
Two	features a higher potential for misuse. Features a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can result in severe physical or emotional dependence.
3	features a potential for abuse less than people in programs 1 and 2 2. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence.
4	features a low potential for abuse relative to people in program 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in program 3.
5	features a low potential for abuse relative to people in program 4. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence.

Infection
X	Interacts with Medication.

Always seek advice from your physician to ensure the information displayed on this page applies to your circumstances.